Compound pharmaceutical composition for coronary heart disease

The invention discloses combined application of atorvastatin calcium and atreleuton in preparation of drugs for treating and preventing coronary heart disease. The invention also provides a compound pharmaceutical composition for treating coronary heart disease. According to the invention, the inhibition effect on inflammation can be improved, hypersensitive C-reactive protein, plasma interleukinand the like can be reduced, the size of coronary plaques can be stabilized, even the effect of reversing plaques can be achieved, the compound pharmaceutical composition can effectively prevent and treat thrombosis and complications of atherosclerotic plaques by inhibiting inflammation, and has a very good protective effect on heart and blood vessels. 本发明公开了一种阿托伐他汀钙和阿曲留通联合施用在制备治疗和预防冠心病药物中的用途，以及一种用于治疗冠心病的复方药物组合物，本发明能够提高对炎症的抑制作用，降低超敏C反应蛋白及血浆白细胞介素等，并且能够稳定冠状动脉斑块的大小，甚至具有逆转斑块的作用，通过对炎症的抑制可以有效预防和治疗动脉粥样硬化斑块发生血栓及形成并发症，对心血管具有很好的保护作用。